Long COVID and recovery from Long COVID: Quality of life impairments and subjective cognitive decline at a median of 2 years after initial infection

Author:

Szewczyk Warren1,Fitzpatrick Annette L1,Fossou Herve1,Gentile Nicole L2,Sotoodehnia Nona3,Vora Surabhi4,West T Eoin5,Bertolli Jeanne6,Cope Jennifer R6,Lin Jin-Mann6,Unger Elizabeth6,Vu Quan M6

Affiliation:

1. Department of Epidemiology, School of Public Health, University of Washington

2. Department of Family Medicine, School of Medicine, University of Washington

3. Cardiovascular Health Research Unit, Department of Medicine, University of Washington

4. Division of Infectious Diseases, Department of Pediatrics, Seattle Children's Hospital

5. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington

6. Centers for Disease Control and Prevention

Abstract

Abstract Background:Quality of life (QoL) and cognition for those with Long COVID is not well-characterized, but existing research suggests impairments in both persist beyond 12 months after initial illness. Methods:In this cross-sectional study, 435 participants with SARS-CoV-2 infection, confirmed with laboratory test or physician diagnosis, between March 2020 and December 2021 completed self-report surveys between March 2022 and September 2022 (n=7305 sent surveys; response rate=6.0%). Multi-domain QoL and cognitive concerns were evaluated using PROMIS-29 and the Cognitive Change Index-12. Those not recovered from COVID-19 at time of survey (“Current Long COVID”; n=181) and those who recovered from COVID-19 in >3 months (“Recovered Long COVID”; n=34), were combined to form a Long COVID group (n=215) and were compared with those who recovered from COVID in ≤3 months (“Without Long COVID”; n=220). Results: Nearly half the participants (47.7%) were surveyed more than 2 years from initial infection (median=23.3 months; IQR=18.6, 26.7). The Long COVID group showed significantly greater proportion of moderate-to-severe impairment in all health domains assessed compared to those Without Long COVID (all p<0.05). The Recovered Long COVID group showed significantly lower prevalence of fatigue, pain, depression, and physical and social function impairment compared to those with Current Long COVID (all p<0.05). However, compared to patients Without Long COVID, the Recovered Long COVID group had greater prevalences of fatigue, pain (P≤0.06) and subjective cognitive decline (61.8% vs 29.1%; p<0.01). Multivariate relative risk (RR) regression indicated Long COVID risk was greater for older age groups (RR range 1.46-1.52; all p≤0.05), those without a bachelor’s degree (RR=1.33; 95% CI=1.03-1.71; p=0.03), and those with 3 or more comorbidities prior to SARS-CoV-2 infection (RR=1.45; 95% CI=1.11-1.90; p<0.01). Each additional symptom experienced during acute COVID-19 was associated with a 14% greater Long COVID risk (RR=1.14, 95% CI=1.10-1.18; p<0.01). Conclusions: Long COVID is associated with long-term cognitive complaints and diminished quality of life. Older age, not having a bachelor’s degree, and pre-existing comorbidities are risk factors for prolonged or non-recovery from COVID-19. Recovery from Long COVID was reported by a subset of those with Long COVID, though clinically significant cognitive complaints, fatigue, and pain persisted.

Publisher

Research Square Platform LLC

Reference50 articles.

1. Post COVID-19 condition (Long COVID) [Internet]. Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.

2. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics;Hirschtick JL;Clin Infect Dis,2021

3. Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. major findings, mechanisms and recommendations. Nature Reviews Microbiology 2023 21:3 [Internet]. 2023;21(3):133–46. Available from: https://www.nature.com/articles/s41579-022-00846-2.

4. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records;Taquet M;Lancet Psychiatry,2021

5. Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clinical Microbiology and Infection [Internet]. 2022;28(5):657–66. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1198743X22000386.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3